These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. [Prevalence of anti-HCV in sera of patients with hepatocellular carcinoma]. Yu ZY. Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):44-6. PubMed ID: 7687532 [Abstract] [Full Text] [Related]
13. Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease. Nalpas B, Driss F, Pol S, Hamelin B, Housset C, Brechot C, Berthelot P. J Hepatol; 1991 Jan; 12(1):70-4. PubMed ID: 1848875 [Abstract] [Full Text] [Related]
14. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Simonetti RG, Cammà C, Fiorello F, Cottone M, Rapicetta M, Marino L, Fiorentino G, Craxì A, Ciccaglione A, Giuseppetti R. Ann Intern Med; 1992 Jan 15; 116(2):97-102. PubMed ID: 1309286 [Abstract] [Full Text] [Related]
16. Significance of hepatitis B virus surface antigen, hepatitis C virus expression in hepatocellular carcinoma and pericarcinomatous tissues. Xuan SY, Xin YN, Chen H, Shi GJ, Guan HS, Li Y. World J Gastroenterol; 2007 Mar 28; 13(12):1870-4. PubMed ID: 17465484 [Abstract] [Full Text] [Related]
18. Hepatitis B, C, and D virus infections in patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma: a comparative study in Niger. Cenac A, Pedroso ML, Djibo A, Develoux M, Pichoud C, Lamothe F, Trepo C, Warter A. Am J Trop Med Hyg; 1995 Apr 28; 52(4):293-6. PubMed ID: 7537942 [Abstract] [Full Text] [Related]